[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 209, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew Craig Kapusta CPA", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 1017357, "exercisedValue": 0, "unexercisedValue": 96250}, {"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 575462, "exercisedValue": 0, "unexercisedValue": 21000}, {"maxAge": 1, "name": "Mr. Richard  Porter Ph.D.", "age": 55, "title": "Chief Business & Scientific Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 732169, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeannette  Potts J.D., Ph.D.", "age": 62, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 635561, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamara  Tugal Ph.D., MBA", "title": "Business Development Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Boyer", "title": "Chief People & Culture Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walid  Abi-Saab M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eileen  Sawyer", "title": "Vice President of Global Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.57, "open": 8.6, "dayLow": 8.42, "dayHigh": 8.94, "regularMarketPreviousClose": 8.57, "regularMarketOpen": 8.6, "regularMarketDayLow": 8.42, "regularMarketDayHigh": 8.94, "payoutRatio": 0.0, "beta": 0.418, "forwardPE": -2.9183009, "volume": 852992, "regularMarketVolume": 852992, "averageVolume": 1113733, "averageVolume10days": 1804230, "averageDailyVolume10Day": 1804230, "bid": 8.83, "ask": 8.94, "bidSize": 2, "askSize": 10, "marketCap": 482906720, "fiftyTwoWeekLow": 3.73, "fiftyTwoWeekHigh": 19.18, "priceToSalesTrailing12Months": 17.806952, "fiftyDayAverage": 12.5957, "twoHundredDayAverage": 9.534925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 617998848, "profitMargins": 0.0, "floatShares": 44295995, "sharesOutstanding": 54076900, "sharesShort": 3050960, "sharesShortPriorMonth": 2439803, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.056399997, "heldPercentInsiders": 0.085930005, "heldPercentInstitutions": 0.77608, "shortRatio": 3.22, "shortPercentOfFloat": 0.056900002, "impliedSharesOutstanding": 54076900, "bookValue": -0.138, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -239556000, "trailingEps": -4.92, "forwardEps": -3.06, "enterpriseToRevenue": 22.788, "enterpriseToEbitda": -3.648, "52WeekChange": 0.8839662, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 8.93, "targetHighPrice": 75.78296, "targetLowPrice": 19.656818, "targetMeanPrice": 37.935955, "targetMedianPrice": 32.761364, "recommendationMean": 1.46154, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 367520992, "totalCashPerShare": 6.796, "ebitda": -169430000, "totalDebt": 500991008, "quickRatio": 9.323, "currentRatio": 9.744, "totalRevenue": 27119000, "revenuePerShare": 0.557, "returnOnAssets": -0.16394, "returnOnEquity": -2.38461, "grossProfits": -132840000, "freeCashflow": -139787504, "operatingCashflow": -182728000, "revenueGrowth": -0.219, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.9626503, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1744402800, "regularMarketTime": 1744401601, "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "regularMarketChangePercent": 4.2007074, "regularMarketPrice": 8.93, "exchange": "NMS", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1113733, "fiftyTwoWeekLowChange": 5.2000003, "fiftyTwoWeekLowChangePercent": 1.394102, "fiftyTwoWeekRange": "3.73 - 19.18", "fiftyTwoWeekHighChange": -10.25, "fiftyTwoWeekHighChangePercent": -0.53441083, "fiftyTwoWeekChangePercent": 88.39662, "earningsTimestamp": 1740657900, "earningsTimestampStart": 1740657900, "earningsTimestampEnd": 1740657900, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.92, "epsForward": -3.06, "epsCurrentYear": -3.7125, "priceEpsCurrentYear": -2.4053872, "fiftyDayAverageChange": -3.6657, "fiftyDayAverageChangePercent": -0.29102787, "twoHundredDayAverageChange": -0.60492516, "twoHundredDayAverageChangePercent": -0.063443094, "priceToBook": -64.71015, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.93, "postMarketChange": 0.0, "regularMarketChange": 0.3600006, "regularMarketDayRange": "8.42 - 8.94", "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]